ScholarIQanswers from OpenAlex & ORCID
H. Guo
ResearcherPublications, citations & collaboration network
H. Guo is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does H. Guo have?
ScholarIQindexed works
H. Guo has 6 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does H. Guo have?
ScholarIQcitation count
H. Guo has 0 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of H. Guo?
ScholarIQh-index
H. Guo has an h-index of 0 in OpenAlex.
What is the i10-index of H. Guo?
ScholarIQi10-index
H. Guo has an i10-index of 0 in OpenAlex.
What is the OpenAlex record for H. Guo?
ScholarIQopenalex
The OpenAlex for H. Guo is on the source record.
What are the most-cited papers on H. Guo?
ScholarIQmost cited works
490MO Niraparib (NIRA) and abiraterone acetate plus prednisone (AAP) in Chinese patients with breast cancer susceptibility gene (BRCA) altered metastatic castration-sensitive prostate cancer (mCSPC): Subgroup analysis of the phase III AMPLITUDE trial
B. Wang, D. Ye, H. Guo, L. Li, Suneel Mundle, F. Shen, Anildeep Singh, Y. Liu, Xiaoyu Jia, L. Han, N. Chen, H. Luo
573P Anatomical adaptability guides approach selection in robotic partial nephrectomy: Equivalent trifecta outcomes with route-specific predictive models
X. Zhen, L. Dai, Q. Ma, W. Yang, H. Guo, C. Ji
574P SHOX2-Mediated lymphatic metastasis in pT1 non-clear cell renal carcinoma: Biomarker-driven risk stratification and combined-modality management
Lina Dai, X. Zhen, Qian Ma, W. Yang, H. Guo, C. Ji
498P Efficacy and safety of triptorelin pamoate 22.5 mg 6-month formulation in Chinese patients with locally advanced or metastatic prostate cancer: A multicentre, single-arm phase IIIb study
S. Jiang, H. Su, H. Guo, M. Liu, Y. Li, G. Shi, J. Bi, Z. Chen, M. Chen, W. He, Z. Yan, J. Zhang, B. Xue, J-Y Zou, X. Shi, D. Ye
489MO A multicenter, single-arm, phase II trial of androgen deprivation therapy in combination with apalutamide in patients with high risk of recurrence after radical prostatectomy (ARES study)
Q. Zhang, L. Xu, X. Qiu, J. Zhuang, S. Zhang, C. Zhou, L. Xu, Haibo Xu, X. Wang, W. Liu, Xiaoyu Jia, H. Guo